As it has always been women’s rights, medical care, and pay have taken a back seat to the needs and wants of men. So it is no surprise that low libido (in women) would definitely not be a front runner for “cause of the year”. Most women that I deal with as a GYN see the issue as taboo or something that at the very least can’t be explored. Although I know that sexual desire and libido are much more complex than just giving a single pill to a woman the issue of hormone imbalance cannot be overlooked.
Women are complex and unique, and must be approached in their intellect, emotions, as well as their body. So the idea that one pill will fix all is definitely a stretch. The sexually mature and expressive woman will need to know what touches, smells, and movements “light her fire” before she can expect to have her partner take her there. So although the hormones can play a huge part in the overall motivation the “sexually satisfying experience” may still need some practice to be achieved.
Now what about this pill? Addyi (Flibanserin) “aka: Female Viagra” works in the brain by stimulating neurotransmitters dealing with dopamine and norepinephrine. In the study 100-mg taken daily increased satisfying sexual experiences (SSE) by 0.5 to 1 per month on average. About 25% of the women in the study increased by 4 or more SSE a month. [If you aren’t having any sex a jump of anywhere from once a month to once a week will be a welcome experience]
To avoid the side effects of low blood pressure, fainting spells, and drowsiness it is suggested to be taken at bedtime. Doctors must get a special certificate,that will be available at the end of the year, in order to prescribe the medication.
Key points about the medication are:
[Shameless commercial]: Pellet therapy achieves great results through testosterone, which is an important hormone involved with regulating sex drive. As people get older, production decreases. Hormone Replacement Therapy with the use of pellets has been around since the 1930s. In our experience we have seen more than 75% of patients see significant increases in sex drive, arousal, and desire. The therapy is NOT FDA regulated but has a great track record for success.